News

Frost & Sullivan’s 2026 Global Company of the Year

12 May 2026

Frost & Sullivan’s 2026 Global Company of the Year

Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.

  • Reset
Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, and Regional Collaboration

25 September 2025

Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, and Regional Collaboration

Avance Clinical, a global CRO headquartered in South Australia, met with Mr Jeff Robinson, South Australian Ambassador to Korea, to advance collaboration opportunities between South Australia and Korea in biotech clinical research.

Avance Clinical Attends Reception Welcoming Australia’s US Ambassador to North Carolina Governor’s Executive Mansion in Raleigh, N.C.

9 September 2025

Avance Clinical Attends Reception Welcoming Australia’s US Ambassador to North Carolina Governor’s Executive Mansion in Raleigh, N.C.

On September 3, 2025, Avance Clinical was honored to attend a special reception at the Executive Mansion in Raleigh, North Carolina, hosted by Governor Josh Stein to welcome His Excellency, The Honorable Kevin Rudd AC, Australia’s Ambassador to the United States.

Avance Clinical Accelerates Time to Pivotal Milestones for More Than 700 Emerging Biotechs

27 August 2025

Avance Clinical Accelerates Time to Pivotal Milestones for More Than 700 Emerging Biotechs

Avance Clinical has now guided 710 emerging biotechs through critical clinical trial inflection points.

Australia Delivers Certainty for US Biotechs in 2025

28 May 2025

Australia Delivers Certainty for US Biotechs in 2025

As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials.

Avance Clinical Honored with Frost & Sullivan’s 2025 Global Customer Value Leadership Award  for Transformative Biotech CRO Services

15 May 2025

Avance Clinical Honored with Frost & Sullivan’s 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services

This award recognizes Avance Clinical’s strategic innovation, operational agility, and unwavering commitment to client success in early-phase clinical trials.

Frost & Sullivan Interview – Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

3 April 2025

Frost & Sullivan Interview – Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs.

Strategic Partnership Between Avance Clinical and Kaohsiung Medical University Chung-Ho Memorial Hospital- Strengthens Asia’s Clinical Trial Network

21 March 2025

Strategic Partnership Between Avance Clinical and Kaohsiung Medical University Chung-Ho Memorial Hospital- Strengthens Asia’s Clinical Trial Network

Avance Clinical has signed a Memorandum of Understanding (MOU) with Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), a top-tier clinical research hospital in Taiwan, recognized for its excellence in conducting high-quality clinical trials and its leadership in medical innovation.

Avance Clinical Partners with China Medical University Hospital in Taiwan to Strengthen Early-to-Late Phase Clinical Trial Pathway

20 March 2025

Avance Clinical Partners with China Medical University Hospital in Taiwan to Strengthen Early-to-Late Phase Clinical Trial Pathway

CMUH is renowned for its excellence in conducting clinical trials, and Avance Clinical specializes in early-phase clinical researchers.

Avance Clinical Signs Memorandum of Understanding with Taichung Veterans General Hospital, Expanding Trial Site Network in Taiwan

20 March 2025

Avance Clinical Signs Memorandum of Understanding with Taichung Veterans General Hospital, Expanding Trial Site Network in Taiwan

Avance Clinical signed a Memorandum of Understanding (MOU) with Taichung Veterans General Hospital (TCVGH), one of Taiwan’s leading medical centers with extensive clinical trial expertise.

Avance Clinical and Taipei Medical University Join Forces to Accelerate Clinical Research and Biotech Innovation in Asia

19 March 2025

Avance Clinical and Taipei Medical University Join Forces to Accelerate Clinical Research and Biotech Innovation in Asia

Avance Clinical as signed a Memorandum of Understanding (MOU) with Taipei Medical University (TMU), one of Taiwan’s leading medical institutions with extensive clinical trial expertise.

Avance Clinical Expands in Asia with Taipei Office to Accelerate Biotech Clinical Trials

18 March 2025

Avance Clinical Expands in Asia with Taipei Office to Accelerate Biotech Clinical Trials

Avance Clinical has further strengthened its presence in Asia with the opening of an office in Taipei, Taiwan.

Global Reach for Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites

17 March 2025

Global Reach for Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites

Avance Clinical is pleased to announce the signing of four Memorandums of Understanding (MOUs) with key clinical trial sites in Taiwan this week.

Proven industry
experience & expertise

500+

Studies in the past 5 years

450+

Experienced team members

18k+

Participants past 5 years

30

Years of CRO experience